Form 4: Cardlytics CFO Alexis DeSieno Reports Stock Transactions

Cardlytics' Chief Financial Officer, Alexis DeSieno, reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Summary

• Alexis DeSieno, the CFO of Cardlytics, Inc. (CDLX), reported transactions involving Cardlytics' common stock.
• On February 14, 2025, 43,750 restricted stock units (RSUs) vested.
• Following the vesting, DeSieno sold 24,778 shares on February 18, 2025, at a weighted average price of $3.398 per share to satisfy tax withholding obligations.
• The remaining shares beneficially owned following the reported transactions totaled 140,948.
• DeSieno also holds 87,500 derivative securities in the form of Restricted Stock Units.

Sentiment

Score: 6

Explanation: The document is neutral. It simply reports required information about stock transactions. The sale of shares to cover taxes is a normal event.

Positives

• The vesting of RSUs indicates that performance milestones or time-based vesting requirements were met.

Negatives

• The sale of shares, even if for tax obligations, could be perceived negatively by some investors if they believe the CFO is reducing their stake in the company.

Risks

• Executive stock sales can sometimes be misinterpreted by the market, potentially leading to short-term price volatility.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. Investors often monitor these transactions for insights into management's confidence in the company's future prospects.

Comparison to Industry Standards

• Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
• Sales to cover tax obligations are a standard practice when RSUs vest.

Stakeholder Impact

• The stock sale could have a minor impact on shareholders if it creates downward pressure on the stock price, although sales to cover tax obligations are usually anticipated.

Key Dates

Keywords

Cardlytics, CDLX, Alexis DeSieno, CFO, Form 4, Stock Sale, Restricted Stock Units, RSU, Vesting, Tax Withholding